丙型肝炎病毒感染细胞和肝脏的代谢组、蛋白质组和转录组联合分析识别与疾病进展相关的通路
研究对丙型肝炎病毒(HCV)感染的类肝细胞和嵌合小鼠进行转录组、蛋白质组和代谢组联合分析,发现HCV感染增加葡萄糖代谢和STAT3信号通路并降低过氧化物酶体功能,过氧化物酶体基因表达改变与肝病患者的结局相关。
要点
- HCV感染类肝细胞后葡萄糖消耗和代谢增加、STAT3信号通路增强、过氧化物酶体功能降低。
- HCV感染细胞和小鼠肝脏中过氧化物酶体功能相关mRNA和蛋白水平显著降低。
- 过氧化物酶体功能缺陷与HCV相关肝硬化、脂肪肝病和肝细胞癌的结局及特征相关。
核心结论
- HCV感染增加葡萄糖代谢和STAT3信号通路,从而降低过氧化物酶体功能;过氧化物酶体基因表达水平改变与肝病患者结局相关。
研究设计与样本
- 对HCV感染的Huh7.5.1dif类肝细胞进行RNA测序、蛋白质组、代谢组和整合基因组分析。
- uPA/SCID小鼠注射HCV感染患者血清,8周后收集肝组织进行RNA测序和蛋白质组分析。
- 在216例HCV感染伴早期肝硬化患者的肝组织和99例肝细胞癌患者的配对活检标本(包括17例有脂肪性肝炎组织学特征)中验证发现。
主要发现
- 在HCV感染细胞中定量了21,950种信使RNA(mRNA)和8,297种蛋白质。
- HCV感染类肝细胞后调节先天免疫应答的mRNA水平显著升高但蛋白水平未升高,研究者认为这是由于这些细胞中翻译受抑制。
- HCV感染类肝细胞增加葡萄糖消耗和代谢及STAT3信号通路,并降低过氧化物酶体功能。
- HCV感染细胞中极长链脂肪酸细胞内蓄积,脂肪肝病患者中也观察到同样现象。
- HCV感染小鼠肝脏细胞中过氧化物酶体功能相关mRNA和蛋白水平显著降低。
关键数值与推荐
- 根据相对过氧化物酶体功能将HCV感染患者的肝硬化肝组织分为2组,评估结局包括Child-Pugh分级、肝细胞癌发生、生存和脂肪性肝炎。
- 根据脂肪性肝炎对肝细胞癌进行分类,结局为相对过氧化物酶体功能。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The mechanisms of hepatitis C virus (HCV) infection, liver disease progression, and hepatocarcinogenesis are only partially understood. We performed genomic, proteomic, and metabolomic analyses of HCV-infected cells and chimeric mice to learn more about these processes. METHODS: Huh7.5.1dif (hepatocyte-like cells) were infected with culture-derived HCV and used in RNA sequencing, proteomic, metabolomic, and integrative genomic analyses. uPA/SCID (urokinase-type plasminogen activator/severe combined immunodeficiency) mice were injected with serum from HCV-infected patients; 8 weeks later, liver tissues were collected and analyzed by RNA sequencing and proteomics. Using differential expression, gene set enrichment analyses, and protein interaction mapping, we identified pathways that changed in response to HCV infection. We validated our findings in studies of liver tissues from 216 patients with HCV infection and early-stage cirrhosis and paired biopsy specimens from 99 patients with hepatocellular carcinoma, including 17 patients with histologic features of steatohepatitis. Cirrhotic liver tissues from patients with HCV infection were classified into 2 groups based on relative peroxisome function; outcomes assessed included Child-Pugh class, development of hepatocellular carcinoma, survival, and steatohepatitis. Hepatocellular carcinomas were classified according to steatohepatitis; the outcome was relative peroxisomal function. RESULTS: We quantified 21,950 messenger RNAs (mRNAs) and 8297 proteins in HCV-infected cells. Upon HCV infection of hepatocyte-like cells and chimeric mice, we observed significant changes in levels of mRNAs and proteins involved in metabolism and hepatocarcinogenesis. HCV infection of hepatocyte-like cells significantly increased levels of the mRNAs, but not proteins, that regulate the innate immune response; we believe this was due to the inhibition of translation in these cells. HCV infection of hepatocyte-like cells increased glucose consumption and metabolism and the STAT3 signaling pathway and reduced peroxisome function. Peroxisomes mediate β-oxidation of very long-chain fatty acids; we found intracellular accumulation of very long-chain fatty acids in HCV-infected cells, which is also observed in patients with fatty liver disease. Cells in livers from HCV-infected mice had significant reductions in levels of the mRNAs and proteins associated with peroxisome function, indicating perturbation of peroxisomes. We found that defects in peroxisome function were associated with outcomes and features of HCV-associated cirrhosis, fatty liver disease, and hepatocellular carcinoma in patients. CONCLUSIONS: We performed combined transcriptome, proteome, and metabolome analyses of liver tissues from HCV-infected hepatocyte-like cells and HCV-infected mice. We found that HCV infection increases glucose metabolism and the STAT3 signaling pathway and thereby reduces peroxisome function; alterations in the expression levels of peroxisome genes were associated with outcomes of patients with liver diseases. These findings provide insights into liver disease pathogenesis and might be used to identify new therapeutic targets.
引用
- Lupberger J, Croonenborghs T, Roca Suarez AA, et al. Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of Hepatitis C Virus-Infected Cells and Liver to Identify Pathways Associated With Disease Development. Gastroenterology. 2019. PMID: 30978357. doi:10.1053/j.gastro.2019.04.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。